The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

In August 2022, President Biden signed the Inflation Reduction Act (IRA) into law. In this OHE Insight, Amanda Cole explores the expert discussions had at ISPOR US 2023.

Insight 3 of this series provides an exploration of revenue guarantee/subscription models and how they could be implemented in the EU.

This is part 2 of the insight series which explores how progress towards an effective pull incentive for antibiotics can be made in Europe.

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...

US drug pricing policies will have global impacts on innovation and access The knowledge generated through biomedical innovation is a public good. One person’s use does not reduce its availability to ...

The OHE Annual Lecture is our opportunity to highlight urgent and important issues facing health systems around the world. OHE’s educational mission is to support, sustain, and enhance the discipline ...

Rare Disease Day is observed on the last day of February every year, and today – February 29th – is truly the rarest day.

Today marks Rare Disease Day 2025. This time last year we published an Article entitled “ Why do we care about rare?”, summarising the origins of rare disease day, the fundamental ambition – to strive ...

Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised.